CONCEPT DESIGN STAGE FOR SELF-SCREEN DHS CHECKPOINT STATION REACHED

Successful Design Stage One for Micro-X Passenger Self-Checking Station – Unlocks $0.7 million second phase of works

ADELAIDE, Australia and SEATTLE, May 24, 2022 /PRNewswire/ — Australian high-tech company Micro-X Ltd (ASX:MX1) (Micro-X or the Company), a global leader in cold cathode x-ray technology for the health and safety markets, is pleased to announce that the company’s U.S. subsidiary, Micro-X, Inc., has crossed the key milestone of the initial system concept under its U.S. Department of Homeland Security-funded development contract (DHS) Science and Technology (S&T) Directorate Rapid Screening Program.

Key points

  • Automated Passenger Checkpoint System Micro-X Concept Design Accepted by DHS
  • Stage 1 design milestone achieved on time and within budget – $0.6 million milestone payment charged
  • Micro-X, as system integrator, led the work with consortium partners Elenium Automation and Monash University, incorporating extensive passenger and stakeholder feedback
  • Concept design leverages advancements made by Micro-X with its Miniature Baggage Scanning Design for DHS
  • One more step towards the deployment of the Micro-X self-checking station for North American airports.

Micro-X has been advised that its initial system concept brief with DHS as part of its passenger self-check point design work has been accepted by DHS and this milestone has been completed with hit. This officially completes the first phase of the design of the automatic passenger checkpoint and approximately $0.6 million was billed to DHS.

In this design phase, Micro-X is leading a consortium of partners including Monash University and Elenium Automation to establish the basic layout and design of a self-checking passenger checkpoint. This work leverages Micro-X’s miniaturized baggage computed tomography (CT) design in combination with unique millimeter wave (mm) person screening technology, to create a small modular self-checking screening station . The layout of the screening station and the workflow of passengers through the self-checking station also incorporated extensive research and passenger interviews by Monash University and stakeholder feedback.

Micro-X’s proprietary automated passenger checkpoint concept delivers a number of important goals that will improve both the passenger experience and airport throughput:

  • small footprint – to allow up to 8 stations in the same footprint as a conventional security check lane;
  • Open design with a well-defined and “controlled” space – ensure passenger comfort; allow easy operator engagement with passengers inside the station; and ensure that the flow of passengers is regulated so that passengers and their baggage are fully screened before entering the secure part of the airport;
  • Simple and consolidated control of passengers and baggage – allows passengers to move quickly through the control;
  • Accommodate passengers with additional needs – people traveling with children or requiring assistance;
  • Technology available – the technology is either currently available and/or funded by DHS S&T to be at prototype level in less than a year; and
  • Security by design: System components and security processes meet security objectives without requiring additional action.

In the next phase of the project, which represents a total of approximately $0.7 million Over the next 6 months, Micro-X will work with its partners to model the proposed system concept using a combination of simulations and mock-ups to test and further refine the concept. During this phase, Micro-X will also continue to refine the workflow through the system to meet the needs of a range of aircraft passengers and to include developments made in miniaturized CT and millimeter wave on-person control. . Micro-X will conclude this next phase by testing the new concept with passengers, airline and airport representatives, as well as DHS and TSA representatives in our Seattle office.

Doctor Brian GonzalesCEO of Micro-X Inc. and General Manager of the Checkpoints Business Unit, said:

“The official presentation of this refined new self-checking checkpoint concept to DHS is an exciting milestone for Micro-X and represents the culmination of extensive research and system design efforts conducted by Micro-X and conducted in Australiathe United States and Europe. We are excited to see the concept of self-screening transform from a vision of blue skies into a realistic and achievable system. Our concept shows that the combination of our unique miniaturized X-ray technology with the many advances in automation and passenger screening could dramatically improve the passenger experience and increase passenger throughput, while maintaining or even improving the level of security at the airport checkpoint. »

About Micro-X

Micro-X Limited (the Company) is an ASX-listed high-tech company that develops and markets a range of innovative products for the global health and safety markets, based on proprietary cold cathode carbon nanotube (CNT) emitter technology ). Electronic control of emitters with this technology enables x-ray products with a significant reduction in size, weight and power requirements, enabling greater mobility and ease of use in existing x-ray markets and a range of new and unique security and defense applications. Micro-X has a fully vertically integrated design and production center at Adelaide, Australia. A growing technical and commercial team based in Seattle rapidly expands Micro-X’s business in the United States.

Micro-X’s product portfolio is built into four high-margin health and safety product lines. The first commercial mobile digital radiology products are being sold for diagnostic imaging in global healthcare, military and veterinary applications. An X-ray camera for improvised explosive device security imaging is under advanced development. The US Department of Homeland Security selected Micro-X to design a next-generation airport checkpoint gate with self-service x-rays. A miniature brain scanner for pre-hospital stroke diagnosis in ambulances is being developed with funding from the Australian Government’s Medical Research Future Fund.

SOURCE Micro-X Limited

Abdul J. Gaspar